SCHEMBL19984429

SCHEMBL19984429

O=C(O)NC(c1ccccc1)c1cccc(OCc2ccc(C(=O)O)cc2)c1

nearest known ligand 0.62

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 5/20 0.62
SMN1; SMN2 Q16637 2/20 0.57
RXRA P19793 2/20 0.57
RXRB P28702 2/20 0.57
RXRG P48443 1/20 0.57
TSHR P16473 1/20 0.57
SRD5A2 P31213 2/20 0.56
NR4A2 P43354 4/20 0.56
NR4A1 P22736 1/20 0.52
NR4A3 Q92570 1/20 0.52
KMT2A Q03164 2/20 0.51
SPHK2 Q9NRA0 1/20 0.49
SPHK1 Q9NYA1 1/20 0.49
MEN1 O00255 1/20 0.48
NPC1 O15118 1/20 0.48
POLB P06746 1/20 0.48
RAB9A P51151 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20373866 1.00 CHRM3 (0.62) CHRM3SMN1; SMN2RXRARXRBRXRG
SCHEMBL19984510 0.90 CHRM3 (0.64) CHRM3SMN1; SMN2KMT2ASPHK2SPHK1
SCHEMBL20373372 0.89 CHRM3 (0.61) CHRM3SMN1; SMN2RXRARXRBRXRG
SCHEMBL15777842 0.88 SMPD1 (0.55) CHRM3SMN1; SMN2RXRARXRBNR4A2
SCHEMBL15777839 0.88 SMPD1 (0.55) CHRM3SMN1; SMN2RXRARXRBNR4A2
SCHEMBL19984677 0.88 RXRA (0.57) CHRM3SMN1; SMN2RXRARXRBRXRG
SCHEMBL19903884 0.86 MAOA (0.53) CHRM3SMN1; SMN2NR4A2KMT2ASPHK2
SCHEMBL14166143 0.86 CHRM3 (0.61) CHRM3SMN1; SMN2RXRARXRBRXRG
SCHEMBL19984689 0.82 CHRM3 (0.64) CHRM3SMN1; SMN2KMT2AMEN1NPC1
SCHEMBL16696961 0.81 CHRM3 (0.49) CHRM3SMN1; SMN2NR4A2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3345904-A1 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY Chiesi Farmaceutici S.p.a. (IT) 2018-07-11 EP disclosed
EP-2928889-B1 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARM SPA (IT) 2018-03-21 EP disclosed